AGENDA.pdf
Thu 09:00 - 09:15 CEST
Introduction by keynote speaker Brad Loncar (Founder of BiotechTV)
Thu 09:15 - 09:35 CEST
Bonesupport
Emil Billbäck (CEO)
Thu 09:40 - 10:00 CEST
C-RAD
Cecilia de Leeuw (CEO), Jonas Reinhammar (Interim CFO)
Thu 10:05 - 10:25 CEST
Ambu
Frederik Futtrup (Associate, Investor Relations)
Thu 10:25 - 10:40 CEST
Coffee Break
Thu 10:40 - 11:00 CEST
CellaVision
Simon Østergaard (President & CEO)
Thu 11:05 - 11:25 CEST
BioGaia
Theresa Agnew (CEO)
Thu 11:30 - 11:50 CEST
BioInvent International
Martin Welschof (CEO)
Thu 11:50 - 12:45 CEST
Lunch Break
Thu 12:45 - 13:05 CEST
Surgical Science
Gisli Hennermark (CEO)
Thu 13:10 - 13:30 CEST
Camurus
Fredrik Tiberg (CEO)
Thu 13:35 - 13:55 CEST
SOBI
Gerard Tobin (Head of Investor Relations)
Thu 14:00 - 14:20 CEST
Panel Discusssion - Orphan Diseases
Brad Loncar (Moderator), Egetis Therapeutics , Immedica , Vicore Pharma
Thu 14:25 - 14:45 CEST
Vicore Pharma
Ahmed Mousa (Chief Executive Officer)
Thu 14:50 - 15:10 CEST
Probi
Per Lindblad (CFO)
Thu 15:10 - 15:25 CEST
Thu 15:25 - 15:45 CEST
BioArctic
Gunilla Osswald (CEO)
Thu 15:50 - 16:10 CEST
Swedencare
Håkan Lagerberg (CEO)
Thu 16:40 - 17:00 CEST
Elekta
Tobias Hägglöv (CFO)
Thu 17:00 - 20:00 CEST
Reception at the venue's rooftop bar The Nest
XVIVO Perfusion
Thomas Rundqvist (Global Communications Director), Max Andersson (Business Development)
Devyser Diagnostics
Fredrik Alpsten (CEO)
Egetis Therapeutics
Nicklas Westerholm (CEO)
Implantica
Henric Forsell (Henric Forsell, VP Market Development & Strategy)
Basilea Pharmaceutica
David Veitch (CEO)
ADDvise Group
Staffan Torstensson (CEO)
Xspray Pharma
Per Andersson (CEO)
ArcticZymes Technologies
Michael Akoh (CEO)
Stille
Torbjörn Sköld (CEO)
Orexo
Robert Rönn (SVP and Head of R&D )
Gubra
Henrik Blou (CEO)
Nanoform Finland Plc
Edward Hæggström (CEO), Albert Hæggström (CFO), Henri von Haartman (Director of Investor Relations)
Xbrane Biopharma
Martin Åmark (CEO)
Thu 16:15 - 16:35 CEST
Mendus
Erik Manting (CEO)
Embla Medical (previously Össur)
Klaus Sindahl (Head of IR)
Guard Therapeutics
Tobias Agervald (CEO)
Biovica International AB
Anders Rylander (CEO)
Midsona
Peter Åsberg (CEO)
Bactiguard
Christine Lind (CEO)
Episurf Medical
Pål Ryfors (CEO)
Arcoma
Mattias Leire (CEO)
Medistim
Kari Krogstad (President & CEO)
Formycon
STEFAN Glombitza (CEO)
IRLAB Therapeutics
Kristina Torfgård (CEO)
Mentice
Göran Malmberg (CEO & Group President)
SyntheticMR
Ulrik Harrysson (CEO)
Medivir
Jens Lindberg (CEO), Pia Baumann (CMO)
Boule Diagnostics
Torben Nielsen (CEO), Holger Lembrer (CFO)
Genovis
Fredrik Olsson (CEO)
Cantargia
Göran Forsberg (CEO)
Carasent
Daniel Öhman (CEO)
